Kiniksa Pharmaceuticals Ltd (NASDAQ:KNSA)
| 13.39 Delayed Data As of Aug 05 |  +1.70 / +14.54%Today’s Change | 7.36 Today|||52-Week Range 15.25 | +13.76% Year-to-Date |
Institutional investors purchased a net $1.5 million shares of KNSA during the quarter ended March 2019. This may signal that the smart money is gaining interest in this company as the 93.18% of the shares outstanding that institutional investors hold is among the lowest in the Pharmaceuticals: Major industry.
| Other institutional | 56.96% |
| Mutual fund holders | 36.22% |
| Individual stakeholders | 15.02% |
Largest Quarterly Institutional
Transactions
Latest Institutional Activity
| 6/30/2022 | INTEGRAL HEALTH ASSET MANAGEMENT... Bought 63.8 Thousand shares of Kiniksa Pharmaceuticals L... |
| 6/29/2022 | BAKER BROS. ADVISORS LP Bought 34.8 Thousand shares of Kiniksa Pharmaceuticals L... |
| 6/30/2022 | LOS ANGELES CAPITAL MANAGEMENT L... Bought 260.00 shares of Kiniksa Pharmaceuticals L... |
Top 10 Owners of Kiniksa Pharmaceuticals Ltd
| Stockholder | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| Pictet Asset Management SA | 10.30% | 3,531,802 | 34,223,161 | -16,847 | -0.47% |
| The Vanguard Group, Inc. | 8.63% | 2,958,038 | 28,663,388 | +120,701 | +4.25% |
| HHLR Advisors Ltd. | 8.52% | 2,920,023 | 28,295,023 | 0 | 0.00% |
| Baker Bros. Advisors LP | 8.27% | 2,834,417 | 27,465,501 | +34,840 | +1.24% |
| BlackRock Fund Advisors | 7.47% | 2,560,463 | 24,810,886 | +4,234 | +0.17% |
| ArrowMark Colorado Holdings LLC | 3.85% | 1,320,977 | 12,800,267 | +47,928 | +3.76% |
| Hudson Bay Capital Management LP | 3.73% | 1,280,000 | 12,403,200 | +230,000 | +21.90% |
| Great Point Partners LLC | 3.26% | 1,118,067 | 10,834,069 | +581,329 | +108.31% |
| Opaleye Management, Inc. | 3.25% | 1,112,500 | 10,780,125 | +87,500 | +8.54% |
| Millennium Management LLC | 2.88% | 988,278 | 9,576,414 | +460,475 | +87.24% |
Top 10 Mutual Funds Holding Kiniksa Pharmaceuticals Ltd
| Mutual fund | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| Pictet - Biotech | 5.65% | 1,934,822 | 18,748,425 | +3,594 | +0.19% |
| Pictet - Global Megatrend Selecti... | 2.96% | 1,014,036 | 9,826,009 | +1,014,036 | -- |
| Vanguard Total Stock Market Index... | 2.46% | 844,389 | 8,182,129 | -89,700 | -9.60% |
| Vanguard Small Cap Index Fund | 2.23% | 764,515 | 7,408,150 | -5,806 | -0.75% |
| FCP Medical - BioHealth | 2.22% | 760,279 | 7,367,104 | +216,502 | +39.81% |
| iShares Russell 2000 ETF | 1.91% | 653,371 | 6,331,165 | -660 | -0.10% |
| Meridian Small Cap Growth Fund | 1.77% | 608,152 | 5,892,993 | 0 | 0.00% |
| Vanguard Small Cap Value Index Fu... | 1.42% | 487,861 | 4,727,373 | -4,325 | -0.88% |
| BlackRock Advantage Small Cap Cor... | 1.20% | 411,001 | 3,982,600 | 0 | 0.00% |
| Nomura Asset World Genome Technol... | 1.10% | 377,639 | 3,659,322 | +203,882 | +117.34% |